By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioMarin Pharmaceutical Inc. 

105 Digital Drive

Novato  California  94949  U.S.A.
Phone: 415-506-6700 Fax: 415-382-7427



Company News
BioMarin (BMRN) Joins The NASDAQ-100 Index 7/27/2015 7:47:41 AM
Investors Gear Up For Exciting News as FDA Sets Dates for BioMarin (BMRN) and Sarepta (SRPT) DMD Drugs 7/21/2015 6:34:03 AM
BioMarin (BMRN) Provides Program Update For Talazoparib In Metastatic Breast Cancer 7/20/2015 6:59:18 AM
BioMarin (BMRN) To Host Second Quarter 2015 Financial Results Conference Call And Webcast On Monday, August 3 At 4:30pm ET 7/15/2015 7:20:09 AM
Sarepta (SRPT) and BioMarin (BMRN) Rivalry Heats Up as Sarepta Shops for Second DMD Drug 7/14/2015 6:01:16 AM
BioMarin (BMRN) Announces FDA Accepts Drisapersen NDA For Treatment Of Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping 6/29/2015 7:33:23 AM
BioMarin (BMRN) Announces European Medicines Agency Validates MAA For Drisapersen For Treatment Of Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping 6/26/2015 6:31:15 AM
BioMarin (BMRN) Surging on Impressive Phase II Dwarfism Data 6/18/2015 6:32:43 AM
BioMarin (BMRN) CEO Jean-Jacques Bienaime Awarded EY Entrepreneur Of The Year 2015 Award In Northern California In Health And Life Sciences 6/15/2015 9:10:12 AM
Alexion (ALXN), BioMarin (BMRN), Sanofi (SAN.PA), Shire (SHPGY) May Be Eyeing Dyax Corp. (DYAX) and Its Rare Genetic Disorder Drug 6/11/2015 6:27:19 AM